eplerenone potassium-sparing
Selected indexed studies
- Diuretics. (, 2012) [PMID:31644115]
- Eplerenone. (, 2012) [PMID:31643265]
- Hypokalemic Periodic Paralysis. (, 1993) [PMID:20301512]
_Worker-drafted node — pending editorial review._
Connections
eplerenone potassium-sparing is a side effect of
Sources
- Diuretics. (2012) pubmed
- Eplerenone. (2012) pubmed
- Hypokalemic Periodic Paralysis. (1993) pubmed
- Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy. (2011) pubmed
- Dose doubling, relative potency, and dose equivalence of potassium-sparing diuretics affecting blood pressure and serum potassium: systematic review and meta-analyses. (2016) pubmed
- Diuretics for Hypertension: A Review and Update. (2016) pubmed
- Aldosterone blockers (mineralocorticoid receptor antagonism) and potassium-sparing diuretics. (2011) pubmed
- Mineralocorticoid receptor antagonists-pharmacodynamics and pharmacokinetic differences. (2016) pubmed
- Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading. (2002) pubmed
- Safety profile of mineralocorticoid receptor antagonists: Spironolactone and eplerenone. (2015) pubmed